Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Page

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
British Journal of Clinical Pharmacology|August 20, 2024
The effect of deprescribing interventions on mortality and health outcomes in older people: An updated systematic review and meta-analysisHui Wen Quek, Amy Page, Kenneth Lee, et al.
Pharmacy (Basel, Switzerland)|March 24, 2023
Evaluation of Medication Prescribing Applications Available in AustraliaRiya Amin, Melissa Cato, Sasha Rahavi, et al.
Exploratory Research in Clinical and Social Pharmacy|May 16, 2023
Perceptions and expectations of health professionals regarding hospital pharmacy services and the roles of hospital pharmacists: A qualitative systematic review and meta-synthesisKyung Min Kirsten Lee, Amy Page, Sangseo Kim, et al.
Infectious Diseases Now|July 4, 2024
Supply of nirmatrelvir/ritonavir and molnupiravir for patients with COVID-19 in the first eight months since listing on the Australian Pharmaceutical Benefits Scheme: A retrospective observational studyDerrick Lopez, Douglas Pritchard, Frank M Sanfilippo, et al.
Diabetes, Obesity & Metabolism|December 10, 2025
No causal link between the supply of GLP-1 receptor agonists and antidepressants: Real-world evidence from the Australian Pharmaceutical Benefits SchemeOsvaldo P Almeida, Amy Page, Erin Kelty, et al.
Journal of Dentistry|November 4, 2025
The prevalence of persistent opioid use following dispensed dental opioid prescriptions in AustraliaLeanne Teoh, Marietta Taylor, Mathew Lim, et al.
The Medical Journal of Australia|June 13, 2019
Potentially suboptimal prescribing of medicines for older Aboriginal Australians in remote areasAmy Page, Zoë Hyde, Kate Smith, et al.
Paediatric and Perinatal Epidemiology|September 6, 2025
Changes in the Dispensing of Antibiotics to Australian Children Between 2013 and 2023: Are We Heading in the Right Direction?Erin Kelty, Ella Tairy, Scott Sims, et al.
Drugs & Aging|August 21, 2023
Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER)Dee Mangin, Larkin Lamarche, Jeffrey A Templeton, et al.
Age and Ageing|May 29, 2023
Deprescribing to optimise health outcomes for frail older people: a double-blind placebo-controlled randomised controlled trial-outcomes of the Opti-med studyChristopher Etherton-Beer, Amy Page, Vasi Naganathan, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
British Journal of Clinical Pharmacology|August 20, 2024
The effect of deprescribing interventions on mortality and health outcomes in older people: An updated systematic review and meta-analysisHui Wen Quek, Amy Page, Kenneth Lee, et al.
Pharmacy (Basel, Switzerland)|March 24, 2023
Evaluation of Medication Prescribing Applications Available in AustraliaRiya Amin, Melissa Cato, Sasha Rahavi, et al.
Exploratory Research in Clinical and Social Pharmacy|May 16, 2023
Perceptions and expectations of health professionals regarding hospital pharmacy services and the roles of hospital pharmacists: A qualitative systematic review and meta-synthesisKyung Min Kirsten Lee, Amy Page, Sangseo Kim, et al.
Infectious Diseases Now|July 4, 2024
Supply of nirmatrelvir/ritonavir and molnupiravir for patients with COVID-19 in the first eight months since listing on the Australian Pharmaceutical Benefits Scheme: A retrospective observational studyDerrick Lopez, Douglas Pritchard, Frank M Sanfilippo, et al.
Diabetes, Obesity & Metabolism|December 10, 2025
No causal link between the supply of GLP-1 receptor agonists and antidepressants: Real-world evidence from the Australian Pharmaceutical Benefits SchemeOsvaldo P Almeida, Amy Page, Erin Kelty, et al.
Journal of Dentistry|November 4, 2025
The prevalence of persistent opioid use following dispensed dental opioid prescriptions in AustraliaLeanne Teoh, Marietta Taylor, Mathew Lim, et al.
The Medical Journal of Australia|June 13, 2019
Potentially suboptimal prescribing of medicines for older Aboriginal Australians in remote areasAmy Page, Zoë Hyde, Kate Smith, et al.
Paediatric and Perinatal Epidemiology|September 6, 2025
Changes in the Dispensing of Antibiotics to Australian Children Between 2013 and 2023: Are We Heading in the Right Direction?Erin Kelty, Ella Tairy, Scott Sims, et al.
Drugs & Aging|August 21, 2023
Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER)Dee Mangin, Larkin Lamarche, Jeffrey A Templeton, et al.
Age and Ageing|May 29, 2023
Deprescribing to optimise health outcomes for frail older people: a double-blind placebo-controlled randomised controlled trial-outcomes of the Opti-med studyChristopher Etherton-Beer, Amy Page, Vasi Naganathan, et al.
Pageof 6